Ask Warren

Eone Diagnomics Genome Center

245620 · KOSDAQ · ₩245620 · EDGC

₩741 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1.2B₩1.6B₩1.7B₩1.8B−₩511M₩4.9B₩5.7B₩7.8B
Cost of sales₩470M₩917M₩982M₩1.1B−₩1.7B₩4.5B₩5B₩5.6B
Gross profit₩753M₩681M₩715M₩694M₩1.2B₩431M₩754M₩2.2B
Operating income−₩716M−₩1.3B−₩359M−₩415M₩700M−₩1.5B−₩4.2B−₩1.9B
Net income−₩25B₩25B₩29B−₩5.9B₩6B−₩525M−₩83B−₩3.5B
Net income to shareholders−₩730M₩25B₩20B−₩436M₩9B−₩525M−₩83B−₩3.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩39B₩71B₩44B₩56B₩53B₩134B₩86B₩143B
Current assets₩14B₩46B₩19B₩19B₩15B₩44B₩45B₩30B
Cash and equivalents₩12B₩40B₩13B₩12B₩7.9B₩12B₩9.5B₩11B
Total liabilities₩16B₩47B₩67B₩50B₩46B₩130B₩130B₩108B
Current liabilities₩6B₩37B₩60B₩43B₩39B₩115B₩122B₩92B
Borrowings₩0₩5B₩33B₩33B₩33B₩61B₩61B₩60B
Total equity₩23B₩24B−₩23B₩6B₩6.4B₩3.6B−₩44B₩35B
Shareholders' equity₩23B₩24B−₩23B₩6B₩6.4B₩2.8B−₩45B₩34B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩12B−₩4.8B−₩3.3B₩4.5B−₩2.2B₩4.5B₩876M−₩499M
Capital spending₩3.8M₩3.9M₩0₩9.6M−₩65M₩83M₩1.2B−₩432M
Free cash flow−₩12B−₩4.8B−₩3.3B₩4.5B−₩2.3B₩4.4B−₩283M−₩930M

Consolidated where available. Amounts in won.

Also known as: Eone Diagnomics Genome Center / EDGC / 245620 / KRX:245620

Source: KRX statistical information